[1] Griswold MG, Fullman N, Hawley C, et al. Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2018, 392: 1015-1035.
[2] Sepanlou SG, Safiri S, Bisignano C, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol, 2020, 5: 245-266.
[3] Sarin SK, Kumar M, Eslam M, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol, 2020, 5: 167-228.
[4] Serra-Burriel M, Graupera I, Torán P, et al. Transient elastography for screening of liver fibrosis: Cost-effectiveness analysis from six prospective cohorts in Europe and Asia. J Hepatol, 2019, 71: 1141-1151.
[5] Colbert S, Thornton L, Richmond R. Smartphone apps for managing alcohol consumption: a literature review. Addict Sci Clin Pract, 2020, 15: 17.
[6] Westwood G, Meredith P, Atkins S, et al. Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease. J Hepatol, 2017, 67: 559-567.
[7] Victor RG, Lynch K, Li N, et al. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med, 2018, 378: 1291-1301.
[8] Lee BP, Terrault NA. Return to Alcohol Use After Liver Transplant: Patterns and Surveillance. Clin Liver Dis, 2018, 12: 160-164.
[9] Asphaug L, Thiele M, Krag A, et al. Cost-Effectiveness of Noninvasive Screening for Alcohol-Related Liver Fibrosis. Hepatology, 2020, 71: 2093-2104.
[10] Parkes J, Roderick P, Harris S, et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut, 2010, 59: 1245-1251.
[11] Thiele M, Madsen BS, Hansen JF, et al. Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease. Gastroenterology, 2018, 154: 1369-1379.
[12] O'Donnell A, Anderson P, Jané-Llopis E, et al. Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015-18. BMJ, 2019, 366:l5274.
[13] Wagenaar AC, Tobler AL, Komro KA. Effects of alcohol tax and price policies on morbidity and mortality: a systematic review. Am J Public Health, 2010, 100: 2270-2278.
[14] Jiang H, Livingston M, Room R, et al. Modelling the effects of alcohol pricing policies on alcohol consumption in subpopulations in Australia. Addiction, 2020, 115: 1038-1049.
[15] Plunk AD, Krauss MJ, Syed-Mohammed H, et al. The Impact of the Minimum Legal Drinking Age on Alcohol-Related Chronic Disease Mortality. Alcohol Clin Exp Res, 2016, 40: 1761-1768.
[16] Kanwal F, Mapaskhi S, Smith D, et al. Implementation of a Population-Based Cirrhosis Identification and Management System. Clin Gastroenterol Hepatol, 2018, 16:1182-1186.e2.
[17] Winder GS, Fernandez AC, Klevering K, et al. Confronting the Crisis of Comorbid Alcohol Use Disorder and Alcohol-Related Liver Disease With a Novel Multidisciplinary Clinic. Psychosomatics, 2020, 61: 238-253.
[18] Williams R, Alexander G, Armstrong I, et al. Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK. Lancet, 2018, 391: 1097-1107.
[19] Komaromy M, Duhigg D, Metcalf A, et al. Project ECHO (Extension for Community Healthcare Outcomes): A new model for educating primary care providers about treatment of substance use disorders. Subst Abus, 2016, 37: 20-24. |
